ArticleClinical and translational radiation oncology2026
Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study - Study protocol.
S Anderson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.